Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis (Q34658787)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis (English)

1 reference

Europe PubMed Central

3 August 2017

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Stella Maria Barrouin-Melo

object named as

Stella Maria Barrouin-Melo

8

0 references

Patrícia Sampaio Tavares Veras

object named as

Patricia Sampaio Tavares Veras

7

1 reference

https://orcid.org/0000-0001-8308-9263

author name string

Consuelo Barreto Fernandes

1

1 reference

Europe PubMed Central

3 August 2017

Jairo Torres Magalhães Junior

2

1 reference

Europe PubMed Central

3 August 2017

Clauceane de Jesus

3

1 reference

Europe PubMed Central

3 August 2017

Bárbara Maria Paraná da Silva Souza

4

1 reference

Europe PubMed Central

3 August 2017

Daniela Farias Larangeira

5

1 reference

Europe PubMed Central

3 August 2017

Deborah Bittencourt Mothé Fraga

6

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

6 January 2014

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

32

1 reference

Europe PubMed Central

3 August 2017

11

1 reference

Europe PubMed Central

3 August 2017

1287-1295

1 reference

Europe PubMed Central

3 August 2017

Comparative microsatellite typing of new world leishmania infantum reveals low heterogeneity among populations and its recent old world origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Visceral leishmaniasis in Brazil: trends and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Can spleen aspirations be safely used for the parasitological diagnosis of canine visceral leishmaniosis? A study on assymptomatic and polysymptomatic animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Adverse vaccinal events in dogs and cats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Humoral immunological profile and parasitological statuses of Leishmune vaccinated and visceral leishmaniasis infected dogs from an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Value of two PCR methods for the diagnosis of canine visceral leishmaniasis and the detection of asymptomatic carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Epidemiology of canine leishmaniasis: prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Transmission potential, skin inflammatory response, and parasitism of symptomatic and asymptomatic dogs with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Temporal IgG subclasses response in dogs following vaccination against Leishmania with Leishmune®

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Canine visceral leishmaniasis: relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Clinical, parasitologic, and immunologic evolution in dogs experimentally infected with sand fly-derived Leishmania chagasi promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Immunologic indicators of clinical progression during canine Leishmania infantum infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Comparison of monoclonal and polyclonal antibodies for the detection of canine IgG1 and IgG2, and associations with infection outcome in Leishmania infantum naturally infected dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Post mortem parasitological evaluation of dogs seroreactive for Leishmania from Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Diagnosis of canine leishmaniasis: conventional and molecular techniques using different tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Relationship of Leishmania-specific IgG levels and IgG avidity with parasite density and clinical signs in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Comparison between splenic and lymph node aspirations as sampling methods for the parasitological detection of Leishmania chagasi infection in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.12.046

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34658787&oldid=1975736065"